Myomo (MYO) Other Non-Current Liabilities (2017 - 2025)

Myomo (MYO) reported Other Non-Current Liabilities of $1.6 million for Q4 2025, up 1354.67% quarter-over-quarter from $113423.0 in Q3 2021.

Myomo (MYO) Other Non-Current Liabilities (2017 - 2025) Analysis & Trends

Myomo has reported Other Non-Current Liabilities for 6 years, with the latest figure at $1.6 million in Q4 2025.

For the quarter ending Q4 2025, Other Non-Current Liabilities changed N/A year-over-year to $1.6 million; the trailing twelve-month figure through Dec 2025 stood at $1.6 million (changed N/A YoY), and the FY2025 full-year result was $1.6 million, changed N/A from the prior year.
Other Non-Current Liabilities for Q4 2025 stood at $1.6 million, up from $113423.0 in the prior quarter.
The five-year high for Other Non-Current Liabilities was $1.6 million in Q4 2025, with the low at $113423.0 in Q1 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn
10	Myomo	49.44 Mn	31.04 Mn	-

Download Data